Emerging role of 18F-FDG PET/CT in Castleman disease: a review.
Castleman disease
Fluorodeoxyglucose F18
HIV
Interleukin-6
Positron emission tomography/computed tomography
Journal
Insights into imaging
ISSN: 1869-4101
Titre abrégé: Insights Imaging
Pays: Germany
ID NLM: 101532453
Informations de publication
Date de publication:
11 Mar 2021
11 Mar 2021
Historique:
received:
01
11
2020
accepted:
04
01
2021
entrez:
12
3
2021
pubmed:
13
3
2021
medline:
13
3
2021
Statut:
epublish
Résumé
Castleman disease (CD) describes a group of rare hematologic conditions involving lymphadenopathy with characteristic histopathology and a spectrum of clinical abnormalities. CD is divided into localized or unicentric CD (UCD) and multicentric CD (MCD) by imaging. MCD is further divided based on etiological driver into human herpesvirus-8-associated MCD, POEMS-associated MCD, and idiopathic MCD. There is notable heterogeneity across MCD, but increased level of pro-inflammatory cytokines, particularly interleukin-6, is an established disease driver in a portion of patients. FDG-PET/CT can help determine UCD versus MCD, evaluate for neoplastic conditions that can mimic MCD clinico-pathologically, and monitor therapy responses. CD requires more robust characterization, earlier diagnosis, and an accurate tool for both monitoring and treatment response evaluation; FDG-PET/CT is particularly suited for this. Moving forward, future prospective studies should further characterize the use of FDG-PET/CT in CD and specifically explore the utility of global disease assessment and dual time point imaging.Trial registration ClinicalTrials.gov, NCT02817997, Registered 29 June 2016, https://clinicaltrials.gov/ct2/show/NCT02817997.
Identifiants
pubmed: 33709329
doi: 10.1186/s13244-021-00963-1
pii: 10.1186/s13244-021-00963-1
pmc: PMC7952491
doi:
Banques de données
ClinicalTrials.gov
['NCT02817997']
Types de publication
Journal Article
Review
Langues
eng
Pagination
35Subventions
Organisme : NHLBI NIH HHS
ID : R01 HL141408
Pays : United States
Références
Theranostics. 2013 Oct 07;3(10):787-801
pubmed: 24312151
J Cardiothorac Surg. 2014 Nov 28;9:170
pubmed: 25431102
Eur J Nucl Med Mol Imaging. 2017 Aug;44(Suppl 1):17-31
pubmed: 28623376
Clin Imaging. 2018 Jul - Aug;50:175-180
pubmed: 29604602
J Comput Assist Tomogr. 2013 Jan-Feb;37(1):1-8
pubmed: 23321826
Br J Haematol. 2005 Apr;129(1):3-17
pubmed: 15801951
Haematologica. 2019 Mar;104(3):444-455
pubmed: 30705099
Radiographics. 2016 Sep-Oct;36(5):1309-32
pubmed: 27618318
J Nucl Med. 2015 Jun;56(6):955-61
pubmed: 25883122
BMC Pulm Med. 2015 Apr 09;15:34
pubmed: 25886851
BMC Surg. 2018 Jan 4;18(1):1
pubmed: 29301533
Leukemia. 2019 Apr;33(4):1035-1038
pubmed: 30607019
Hematol Oncol Clin North Am. 2018 Feb;32(1):89-106
pubmed: 29157622
Blood. 2014 May 8;123(19):2924-33
pubmed: 24622327
Rev Esp Med Nucl. 2009 May-Jun;28(3):159-66
pubmed: 19558958
Surg Pathol Clin. 2019 Sep;12(3):849-863
pubmed: 31352991
Cancer Imaging. 2011 Jun 15;11:52-5
pubmed: 21684830
Blood. 2017 Mar 23;129(12):1658-1668
pubmed: 28100459
Br J Radiol. 2015 May;88(1049):20140670
pubmed: 25710283
Radiographics. 2011 Oct;31(6):1793-807
pubmed: 21997995
Blood Rev. 2018 May;32(3):225-234
pubmed: 29223447
Blood. 2017 Mar 23;129(12):1646-1657
pubmed: 28087540
Leuk Lymphoma. 2015 May;56(5):1252-60
pubmed: 25120049
Eur J Nucl Med Mol Imaging. 2014 Nov;41(11):2158-60
pubmed: 24993455
J Nucl Med Technol. 2020 Sep;48(3):278-282
pubmed: 31811061
Blood. 2017 Apr 13;129(15):2143-2147
pubmed: 28143881
J Nucl Med. 2018 Jan;59(1):25-30
pubmed: 28611244
Iran J Med Sci. 2014 Mar;39(2 Suppl):158-70
pubmed: 24753638
Am J Hematol. 2019 Jul;94(7):812-827
pubmed: 31012139
Am J Nucl Med Mol Imaging. 2020 Feb 25;10(1):66-73
pubmed: 32211220
J Nucl Med. 1997 Aug;38(8):1211-2
pubmed: 9255152
Nucl Med Commun. 2020 Feb;41(2):162-168
pubmed: 31860525
PET Clin. 2019 Jul;14(3):331-340
pubmed: 31084773
Acta Oncol. 2004;43(8):698-704
pubmed: 15764213
Eur J Nucl Med Mol Imaging. 2019 Aug;46(9):1768-1772
pubmed: 31183636
Patient Relat Outcome Meas. 2018 Jan 12;9:35-41
pubmed: 29391839
Clin Nucl Med. 2013 May;38(5):339-42
pubmed: 23429387
Blood. 2012 Mar 8;119(10):2228-33
pubmed: 22223822
Blood. 2012 May 31;119(22):5173-81
pubmed: 22490805
Hematol Oncol Clin North Am. 2018 Feb;32(1):53-64
pubmed: 29157619
Radiology. 2018 Apr;287(1):303-312
pubmed: 29357275
Eur J Radiol. 2012 Jan;81(1):123-31
pubmed: 20643523
Ann Thorac Surg. 2014 May;97(5):1798-800
pubmed: 24792274
Med Oncol. 2010 Dec;27(4):1171-8
pubmed: 19937164
Int J STD AIDS. 2018 Jun;29(7):691-694
pubmed: 29198183
Radiology. 2018 Jan;286(1):260-270
pubmed: 29040022
Cancer Imaging. 2019 Jul 25;19(1):53
pubmed: 31345268
Ann Oncol. 2009 Apr;20(4):775-9
pubmed: 19179554
Blood. 2013 Dec 19;122(26):4189-98
pubmed: 24174627
J Med Case Rep. 2008 Apr 03;2:99
pubmed: 18387191
Eur J Nucl Med Mol Imaging. 2020 Oct;47(11):2493-2498
pubmed: 31982989
J Nucl Cardiol. 2020 May 10;:
pubmed: 32390112
Oncol Lett. 2018 Feb;15(2):2407-2412
pubmed: 29434951
Eur J Nucl Med Mol Imaging. 2011 Jun;38(6):1158-70
pubmed: 21225422
Eur J Nucl Med Mol Imaging. 2020 Dec;47(13):3107-3117
pubmed: 32567005
Blood Res. 2015 Dec;50(4):260-2
pubmed: 26770956
Eur J Nucl Med Mol Imaging. 2013 May;40(5):779-87
pubmed: 23361859
Hell J Nucl Med. 2017 May-Aug;20(2):169-171
pubmed: 28697195
Oncologist. 2011;16(4):497-511
pubmed: 21441298
J Clin Invest. 2019 Aug 13;129(10):4451-4463
pubmed: 31408438
Rev Esp Med Nucl Imagen Mol. 2012 May-Jun;31(3):142-4
pubmed: 22133346
J Med Case Rep. 2015 Feb 28;9:45
pubmed: 25884809
Cancer. 2015 Oct 1;121(19):3390-2
pubmed: 26177743
Am J Hematol. 2008 Jun;83(6):498-503
pubmed: 18260115
Cureus. 2015 Nov 17;7(11):e380
pubmed: 26719823
Blood. 2018 Nov 15;132(20):2115-2124
pubmed: 30181172
Onco Targets Ther. 2015 Jul 30;8:1967-70
pubmed: 26257526
Eur J Nucl Med Mol Imaging. 2009 Apr;36(4):648-52
pubmed: 19050873
Onco Targets Ther. 2014 May 23;7:789-98
pubmed: 24920919
Pathol Oncol Res. 2013 Jul;19(3):345-51
pubmed: 23516126
Adv Anat Pathol. 2009 Jul;16(4):236-46
pubmed: 19546611
Case Rep Otolaryngol. 2015;2015:691701
pubmed: 26509092
Leuk Lymphoma. 2007 Sep;48(9):1881-3
pubmed: 17786732
J Neurol Sci. 2020 Jun 15;413:116771
pubmed: 32172013
Med Phys. 2011 May;38(5):2715-23
pubmed: 21776808
Cancer Sci. 2018 Jan;109(1):199-206
pubmed: 29124835
Acad Radiol. 2016 Sep;23(9):1123-9
pubmed: 27283073
J Nucl Med. 2020 Oct;61(10):1520-1527
pubmed: 32060218
Ann Transl Med. 2016 Feb;4(3):58
pubmed: 26904580
Eur J Nucl Med Mol Imaging. 2015 Feb;42(2):328-54
pubmed: 25452219
Clin Adv Hematol Oncol. 2010 Jul;8(7):486-98
pubmed: 20864917
Br J Haematol. 2018 Jan;180(2):206-216
pubmed: 29143319